Nwam LLC Makes New Investment in Astera Labs, Inc. $ALAB

Nwam LLC acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB) in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 1,861 shares of the company’s stock, valued at approximately $168,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Oliver Lagore Vanvalin Investment Group acquired a new stake in shares of Astera Labs during the second quarter worth $29,000. Bernard Wealth Management Corp. acquired a new stake in shares of Astera Labs in the second quarter valued at approximately $36,000. Harbour Investments Inc. increased its position in Astera Labs by 351.7% during the first quarter. Harbour Investments Inc. now owns 795 shares of the company’s stock worth $47,000 after acquiring an additional 619 shares during the period. Migdal Insurance & Financial Holdings Ltd. acquired a new stake in Astera Labs during the first quarter worth approximately $48,000. Finally, Hazlett Burt & Watson Inc. raised its holdings in shares of Astera Labs by 1,670.0% during the 1st quarter. Hazlett Burt & Watson Inc. now owns 885 shares of the company’s stock worth $53,000 after buying an additional 835 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Stock Down 8.4%

Shares of NASDAQ ALAB opened at $144.47 on Friday. The stock’s 50 day moving average price is $194.44 and its 200-day moving average price is $142.70. Astera Labs, Inc. has a twelve month low of $47.13 and a twelve month high of $262.90. The company has a market capitalization of $24.40 billion, a PE ratio of 130.15, a PEG ratio of 2.94 and a beta of 1.37.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The firm had revenue of $230.58 million during the quarter, compared to the consensus estimate of $206.42 million. During the same period in the prior year, the firm earned $0.23 EPS. The company’s revenue was up 103.9% compared to the same quarter last year. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, research analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the stock. Susquehanna raised their target price on shares of Astera Labs from $80.00 to $125.00 and gave the company a “neutral” rating in a research report on Thursday, August 7th. Northland Capmk downgraded Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Tuesday, July 22nd. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Astera Labs in a report on Wednesday, October 8th. Evercore ISI boosted their price target on shares of Astera Labs from $104.00 to $215.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 6th. Finally, Barclays reissued an “equal weight” rating and set a $155.00 target price on shares of Astera Labs in a research note on Monday, October 20th. Thirteen equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $181.59.

Insider Activity at Astera Labs

In other news, Director Jack R. Lazar sold 22,500 shares of the stock in a transaction on Wednesday, August 27th. The shares were sold at an average price of $178.42, for a total value of $4,014,450.00. Following the transaction, the director owned 97,351 shares of the company’s stock, valued at $17,369,365.42. This represents a 18.77% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Jitendra Mohan sold 91,441 shares of the firm’s stock in a transaction dated Monday, August 18th. The shares were sold at an average price of $183.51, for a total value of $16,780,337.91. Following the sale, the chief executive officer owned 2,170,877 shares in the company, valued at $398,377,638.27. The trade was a 4.04% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 434,480 shares of company stock valued at $77,881,380 in the last quarter. 12.50% of the stock is currently owned by company insiders.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.